Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats

Abe, 1980, Effects of an orally effective converting enzyme inhibitor (YS-980) on renal function in dogs, J. Pharmacol. Exp. Ther., 214, 166 Antonaccio, 1979, The effects of captopril, propranolol and indomethacin on blood pressure and plasma renin activity in spontaenously hypertensive and normotensive rats, 162, 429 Antonaccio, 1979, Contribution of the kidneys but not the adrenal glands to the acute antihypertensive effects of captopril in SH rats, Clin. Sci., 57, 127S, 10.1042/cs057127s Antonaccio, 1979, Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats, Jap. J. Pharmacol., 29, 285, 10.1254/jjp.29.285 Bengis, 1978, Long-term blockade of angiotensin formation in various normotensive and hypertensive rat models using converting enzyme inhibitor (SQ 14,225), Circ. Res., 43, I Colquhoun, 1971 Dunnett, 1964, New tables for multiple comparisons with a control, Biometrics, 20, 492, 10.2307/2528490 Ferrone, 1979, Preventions of the development of spontaneous hypertension in rats by captopril (SQ 14,225), European J. Pharmacol., 60, 131, 10.1016/0014-2999(79)90211-5 Freeman, 1979, Effects of continuous converting enzyme blockade on renovascular hypertension in the rat, Am. J. Physiol., 236, F21 Gross, 1981, Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor response in vivo, J. Pharmacol. Exp. Ther., 216, 552 Hall, 1979, Chronic blockade of angiotensin II formation during sodium deprivation, Am. J. Physiol., 237, F424 Hutchinson, 1980, Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats, Hypertension, 2, 119, 10.1161/01.HYP.2.2.119 Hutchinson, 1981, Blood pressure responses of conscious rats to intracerebroventricular and peripheral administration of the angiotensin converting enzyme inhibitor, captopril, Cardiovasc. Pharmacol. Laffan, 1978, Antihypertensive activity in rats of SQ 14,225, an orally active inhibitor of angiotensin converting enzyme, J. Pharmacol. Exp. Ther., 204, 281 Marks, 1980, Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14,225): the role of factors other than renin-angiotensin blockade in the rat, Clin. Sci., 58, 1, 10.1042/cs0580001 McCaa, 1978, The effects of angiotensin I-converting enzyme inhibitors on arterial blood pressure and urinary sodium excretion. Role of the renal renin-angiotensin and kallikrein-kinin systems, Circ. Res., 43, I Miyamori, 1980, Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect of indomethacin, Clin. Exp. Hyper., 2, 935, 10.3109/10641968009037152 Morton, 1980, The effect of captopril on blood pressure and angiotensin I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme, Clin. Sci., 58, 445, 10.1042/cs0580445 Muirhead, 1978, Antihypertensive action of the orally active converting enzyme inhibitor (SQ 14,225) in spontneously hypertensive rats, Clin. Sci., 43, 1 Murthy, 1978, The mechanism of bradykinin potentiation after inhibition of angiotensin-converting enzyme by SQ14,225 in conscious rabbits, Circ. Res., 43, 1 Patchett, 1980, A new class of angiotensin converting enzyme inhibitors, Nature, 288, 280, 10.1038/288280a0 Peach, 1074, 400 Rubin, 1978, Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats, European J. Pharmacol., 51, 377, 10.1016/0014-2999(78)90429-6 Rubin, 1978, Captopril (SQ 14,225) (D-3-mercapto-2-methylpropanoyl-L-Proline): A novel orally active inhibitor of angiotensin-converting enzyme and active inhibitor of angiotensin-converting enzyme and antihypertensive agent, Prog. Cardiovasc. Dis., 21, 183, 10.1016/0033-0620(78)90024-5 Sen, 1980, Effect of converting enzyme inhibitor (SQ 14,225) on myocardial hypertrophy in spontaneously hypertensive rats, Hypertension, 2, 169, 10.1161/01.HYP.2.2.169 Stamler, 1980, The central and peripheral effects of captopril (SQ 14,225) on the arterial pressure of the spontaneously hypertensive rat, Brain Res., 186, 499, 10.1016/0006-8993(80)90998-1 Swartz, 1980, Captopril-induced changes in prostaglandin production, J. Clin. Invest., 65, 1257, 10.1172/JCI109788 Sweet, 1981, Antihypertensive activity of N-[(S)-1-ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421) an orally active converting enzyme inhibitor, J. Pharmacol. Exp. Ther., 216, 558 Sweet, 1979, Cardiovascular properties of antihypertensive drugs in a model of severe renal hypertension, J. Pharm. Meth., 2, 223, 10.1016/0160-5402(79)90004-4 Thurston, 1978, Converting enzyme inhibitors and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor, Circ. Res., 42, 588, 10.1161/01.RES.42.5.588 Tree, 1980, Evidence that the acute hypotensive effect of captopril is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect, Clin. Sci., 10.1042/cs0590451 Unger, 1981, Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 ins spontaneously hypertensive rats, Clin. Exp. Hyper., 10.3109/10641968109037172 Vollmer, 1977, Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chlorolose anesthesized cats, European J. Pharmacol., 45, 117, 10.1016/0014-2999(77)90081-4 Waeber, 1980, Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril, Hypertension, 2, 236, 10.1161/01.HYP.2.2.236